Home » Prices » NASDAQ:HARP

Harpoon Therapeutics, Inc. NASDAQ:HARP

Today's live share price, quote history, chart & news

Price:
16.59 USD
Change:
-0.9 (-5.15%)
Key Stats
Price open 17.5
Previous close 17.49
Market cap 414.72M
Volume 121.41K
Day high 17.5
Day low 16.25
Year high 25.02
Year low 10.27
Year to date change 7.79%
P/E Ratio -7.47
Company Profile
Fundamentals
Insider Information
News

About Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which develops a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient's own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. Using its proprietary Tri-specific T cell Activating Construct (TriTACs) platform, Harpoon is developing a pipeline of novel TriTACs initially focused on the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA.

Company information

Company name
Harpoon Therapeutics, Inc.
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
61
CEO
Gerald McMahon
Address
131 Oyster Point Boulevard, South San Francisco, CA, 94080
Country
United States
Contact information
1.650.443.7400
Website
http://www.harpoontx.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.